NCT00362440View on ClinicalTrials.gov

Combination of Insulin Sensitizer and Leptin as Treatment for the HAART -Induced Metabolic Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

May 31, 2011

Study Completion Date

June 30, 2011

Conditions
HIV Lipodystrophy
Interventions
DRUG

Leptin

DRUG

Pioglitazone or metformin

DRUG

Placebo

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
collaborator

American Diabetes Association

OTHER

lead

Beth Israel Deaconess Medical Center

OTHER

NCT00362440 - Combination of Insulin Sensitizer and Leptin as Treatment for the HAART -Induced Metabolic Syndrome | Biotech Hunter | Biotech Hunter